According to HSAs June 2025 approval notice, Tirzepatide KwikPen was approved in Singapore for weight management, including weight loss and weight maintenance, in adults with an initial BMI of at least 30, or BMI 27 to under 30 with at least one weight-related comorbid condition such as hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes
Kidney problems: Symptoms include changes in urination or swelling in your legs or ankles
If youre working with a trusted medical practice, we handle this for you by sending your prescription to a verified pharmacy
Ensure they are in a thermal or insulated case and not in direct contact with ice packs , which could cause freezing which can damage the medication
Rotating injection sites week to week prevents lipohypertrophy (thickened fatty tissue) and reduces cumulative irritation
If you do not receive an email from Truemed, please email [email protected]